{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T03:18:56Z","timestamp":1792725536987,"version":"4.5.0"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2021,7,15]],"date-time":"2021-07-15T00:00:00Z","timestamp":1626307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,7,15]],"date-time":"2021-07-15T00:00:00Z","timestamp":1626307200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2021,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Rationale<\/jats:title>\n                <jats:p>Autism spectrum disorder (ASD) is a neurodevelopmental condition characterized by deficits in social communication and interaction and restricted, repetitive behaviors. The unmet medical need in ASD is considerable since there is no approved pharmacotherapy for the treatment of these deficits in social communication, interaction, and behavior. Cariprazine, a dopamine D<jats:sub>3<\/jats:sub>-preferring D<jats:sub>3<\/jats:sub>\/D<jats:sub>2<\/jats:sub> receptor partial agonist, is already approved for the treatment of schizophrenia and bipolar I disorder in adults; investigation in patients with ASD is warranted.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Objectives<\/jats:title>\n                <jats:p>The aim of this study was to investigate the effects of cariprazine, compared with risperidone and aripiprazole, in the rat prenatal valporic acid (VPA) exposure model on behavioral endpoints representing the core and associated symptoms of ASD.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>To induce the ASD model, time-mated Wistar rat dams were treated with VPA during pregnancy. Male offspring were assigned to groups and studied in a behavioral test battery at different ages, employing social play, open field, social approach-avoidance, and social recognition memory tests. Animals were dosed orally, once a day for 8\u00a0days, with test compounds (cariprazine, risperidone, aripiprazole) or vehicle before behavioral assessment.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Cariprazine showed dose-dependent efficacy on all behavioral endpoints. In the social play paradigm, only cariprazine was effective. On the remaining behavioral endpoints, including the reversal of hyperactivity, risperidone and aripiprazole displayed similar efficacy to cariprazine.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>In the present study, cariprazine effectively reversed core behavioral deficits and hyperactivity present in juvenile and young adult autistic-like rats. These findings indicate that cariprazine may be useful in the treatment of ASD symptoms.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00213-021-05851-6","type":"journal-article","created":{"date-parts":[[2021,7,15]],"date-time":"2021-07-15T11:02:51Z","timestamp":1626346971000},"page":"2381-2392","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Cariprazine alleviates core behavioral deficits in the prenatal valproic acid exposure model of autism spectrum disorder"],"prefix":"10.1007","volume":"238","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4849-3591","authenticated-orcid":false,"given":"Viktor","family":"Rom\u00e1n","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nika","family":"Adham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew G.","family":"Foley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynsey","family":"Hanratty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bence","family":"Farkas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bal\u00e1zs","family":"Lendvai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9la","family":"Kiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,15]]},"reference":[{"key":"5851_CR1","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association (2013) Diagnostic and Statistical Manual of Mental Disorders\u00a0(5th ed.)","DOI":"10.1176\/appi.books.9780890425596"},{"issue":"5","key":"5851_CR2","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1002\/aur.1395","volume":"7","author":"DA Amodeo","year":"2014","unstructured":"Amodeo DA, Jones JH, Sweeney JA, Ragozzino ME (2014) Risperidone and the 5-HT2A receptor antagonist M100907 improve probabilistic reversal learning in BTBR T + tf\/J mice. Autism Res 7(5):555\u2013567","journal-title":"Autism Res"},{"key":"5851_CR3","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1038\/npp.2014.59","volume":"39","author":"JA Becker","year":"2014","unstructured":"Becker JA, Clesse D, Spiegelhalter C, Schwab Y, Le Merrer J, Kieffer BL (2014) Autistic-like syndrome in mu opioid receptor null mice is relieved by facilitated mGluR4 activity. Neuropsychopharmacology 39:2049\u20132060","journal-title":"Neuropsychopharmacology"},{"issue":"Suppl 1","key":"5851_CR4","doi-asserted-by":"publisher","first-page":"S17","DOI":"10.1186\/1742-9994-12-S1-S17","volume":"12","author":"V Brust","year":"2015","unstructured":"Brust V, Schindler PM, Lewejohann L (2015) Lifetime development of behavioural phenotype in the house mouse (Mus musculus). Front Zool 12(Suppl 1):S17","journal-title":"Front Zool"},{"issue":"3","key":"5851_CR5","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1124\/jpet.105.092155","volume":"315","author":"ES Burstein","year":"2005","unstructured":"Burstein ES, Ma J, Wong S, Gao Y, Pham E, Knapp AE, Nash NR, Olsson R, Davis RE, Hacksell U, Weiner DM, Brann MR (2005) Intrinsic efficacy of antipsychotics at human D2, D3, and D4 dopamine receptors: identification of the clozapine metabolite N-desmethylclozapine as a D2\/D3 partial agonist. J Pharmacol Exp Ther 315(3):1278\u20131287","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"5851_CR6","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.pbb.2010.09.012","volume":"97","author":"KK Chadman","year":"2011","unstructured":"Chadman KK (2011) Fluoxetine but not risperidone increases sociability in the BTBR mouse model of autism. Pharmacol Biochem Behav 97(3):586\u2013594","journal-title":"Pharmacol Biochem Behav"},{"key":"5851_CR7","doi-asserted-by":"publisher","first-page":"2513","DOI":"10.1523\/JNEUROSCI.4712-05.2006","volume":"26","author":"G Chen","year":"2006","unstructured":"Chen G, Kittler JT, Moss SJ, Yan Z (2006) Dopamine D3 receptors regulate GABAA receptor function through a phospho-dependent endocytosis mechanism in nucleus accumbens. J Neurosci 26:2513\u20132521","journal-title":"J Neurosci"},{"issue":"3","key":"5851_CR8","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1017\/S1092852913000680","volume":"19","author":"YK Choi","year":"2014","unstructured":"Choi YK, Adham N, Kiss B, Gyerty\u00e1n I, Tarazi FI (2014) Long-term effects of cariprazine exposure on dopamine receptor subtypes. CNS Spectr 19(3):268\u2013277","journal-title":"CNS Spectr"},{"key":"5851_CR9","doi-asserted-by":"publisher","first-page":"5846","DOI":"10.1523\/JNEUROSCI.0310-17.2017","volume":"37","author":"RL Clarkson","year":"2017","unstructured":"Clarkson RL, Liptak AT, Gee SM, Sohal VS, Bender KJ (2017) D3 receptors regulate excitability in a unique class of prefrontal pyramidal cells. J Neurosci 37:5846\u20135860","journal-title":"J Neurosci"},{"key":"5851_CR10","doi-asserted-by":"crossref","unstructured":"Cohen LS, Pella C (2019) Cariprazine in autism spectrum disorder and intellectual disability disorder. Glob J Intellect Dev Disabil 6(4):71\u201375","DOI":"10.19080\/GJIDD.2019.06.555694"},{"key":"5851_CR11","doi-asserted-by":"crossref","unstructured":"Cosi C, Martel JC, Auclair AL Collo G, Cavalleri L, Heusler P, Leriche,L, Gaudoux F, Sokoloff P, Moser PC, Gatti-McArthur S (2021) Pharmacology profile of F17464, a dopamine D3 receptor preferential antagonist. Eur J Pharmacol 890:173635","DOI":"10.1016\/j.ejphar.2020.173635"},{"key":"5851_CR12","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.neubiorev.2016.09.031","volume":"71","author":"N David","year":"2016","unstructured":"David N, Schneider TR, Peiker I, Al-Jawahiri R, Engel AK, Milne E (2016) Variability of cortical oscillation patterns: a possible endophenotype in autism spectrum disorders? Neurosci Biobehav Rev 71:590\u2013600","journal-title":"Neurosci Biobehav Rev"},{"key":"5851_CR13","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1038\/npp.2010.246","volume":"36","author":"MR Diaz","year":"2011","unstructured":"Diaz MR, Chappell AM, Christian DT, Anderson NJ, McCool BA (2011) Dopamine D3-like receptors modulate anxiety-like behavior and regulate GABAergic transmission in the rat lateral\/basolateral amygdala. Neuropsychopharmacology 36:1090\u20131103","journal-title":"Neuropsychopharmacology"},{"issue":"12","key":"5851_CR14","doi-asserted-by":"publisher","first-page":"e1574","DOI":"10.4088\/JCP.15m09997","volume":"76","author":"S Durgam","year":"2015","unstructured":"Durgam S, Cutler AJ, Lu K, Migliore R, Ruth A, Laszlovszky I, N\u00e9meth G, Meltzer HY (2015a) Cariprazine in acute exacerbation of schizophrenia: a fixed-dose, phase 3, randomized, double-blind, placebo- and active-controlled trial. J Clin Psychiatry 76(12):e1574-1582","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"5851_CR15","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1111\/bdi.12238","volume":"17","author":"S Durgam","year":"2015","unstructured":"Durgam S, Starace A, Li D, Migliore R, Ruth A, N\u00e9meth G, Laszlovszky I (2015b) The efficacy and tolerability of cariprazine in acute mania associated with bipolar I disorder: a phase II trial. Bipolar Disord 17(1):63\u201375","journal-title":"Bipolar Disord"},{"issue":"1","key":"5851_CR16","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.psc.2009.12.002","volume":"33","author":"P El-Fishawy","year":"2010","unstructured":"El-Fishawy P, State MW (2010) The genetics of autism: key issues, recent findings and clinical implications. Psychiatr Clin North Am 33(1):83\u2013105","journal-title":"Psychiatr Clin North Am"},{"issue":"4","key":"5851_CR17","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s40265-013-0021-7","volume":"73","author":"C Farmer","year":"2013","unstructured":"Farmer C, Thurm A, Grant P (2013) Pharmacotherapy for the core symptoms in autistic disorder: current status of the research. Drugs 73(4):303\u2013314","journal-title":"Drugs"},{"issue":"4","key":"5851_CR18","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/j.neuropharm.2012.05.042","volume":"63","author":"AG Foley","year":"2012","unstructured":"Foley AG, Gannon S, Rombach-Mullan N, Prendergast A, Barry C, Cassidy AW, Regan CM (2012) Class I histone deacetylase inhibition ameliorates social cognition and cell adhesion molecule plasticity deficits in a rodent model of autism spectrum disorder. Neuropharmacology 63(4):750\u2013760","journal-title":"Neuropharmacology"},{"issue":"1\u20132","key":"5851_CR19","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/S0166-4328(00)00193-5","volume":"114","author":"PL Gendreau","year":"2000","unstructured":"Gendreau PL, Petitto JM, Petrova A, Gari\u00e9py J, Lewis MH (2000) D(3) and D(2) dopamine receptor agonists differentially modulate isolation-induced social-emotional reactivity in mice. Behav Brain Res 114(1\u20132):107\u2013117","journal-title":"Behav Brain Res"},{"key":"5851_CR20","doi-asserted-by":"crossref","unstructured":"Graff-Guerrero A, Mamo D, Shammi CM, Mizrahi R, Marcon O, Barsoum P, Rusjan P, Houle S, Wilson AA, Kapur S (2009) The effect of antipsychotics on the high-affinity state of D2 and D3 receptors: a positron emission tomography study with [11C]-(+)-PHNO. Arch Gen Psychiatry 66:606\u2013615","DOI":"10.1001\/archgenpsychiatry.2009.43"},{"key":"5851_CR21","doi-asserted-by":"crossref","unstructured":"Girgis RR, Slifstein M, D\u2019Souza D, Lee Y, Periclou A, Ghahramani P, Laszlovszky I, Durgam S, Adham N, Nabulsi N, Huang Y, Carson RE, Kiss B, Kap\u00e1s M, Abi-Dargham A, Rakhit A (2016) Preferential binding to dopamine D3 over D2 receptors by cariprazine in patients with schizophrenia using PET with the D3\/D2 receptor ligand [11C]-(+)-PHNO. Psychopharmacology 233(19\u201320):3503\u20133512","DOI":"10.1007\/s00213-016-4382-y"},{"key":"5851_CR22","first-page":"S476","volume":"43","author":"R Girgis","year":"2017","unstructured":"Girgis R, Abi-Dargham A, Slifstein M, Chen L, Periclou A, Adham N, Earley W (2017) In vivo dopamine D3 and D2 receptor occupancy profile of cariprazine versus aripiprazole: a PET study. Neuropsychopharmacology 43:S476\u2013S652","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"5851_CR23","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1007\/s11689-009-9023-x","volume":"1","author":"N Gogolla","year":"2009","unstructured":"Gogolla N, Leblanc JJ, Quast KB, S\u00fcdhof TC, Fagiolini M, Hensch TK (2009) Common circuit defect of excitatory-inhibitory balance in mouse models of autism. J Neurodev Disord 1(2):172\u2013181","journal-title":"J Neurodev Disord"},{"issue":"2","key":"5851_CR24","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1111\/j.1471-4159.2010.07104.x","volume":"116","author":"GG Gould","year":"2011","unstructured":"Gould GG, Hensler JG, Burke TF, Benno RH, Onaivi ES, Daws LC (2011) Density and function of central serotonin (5-HT) transporters, 5-HT1A and 5-HT2A receptors, and effects of their targeting on BTBR T+tf\/J mouse social behavior. J Neurochem 116(2):291\u2013303","journal-title":"J Neurochem"},{"issue":"6","key":"5851_CR25","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/j.neuint.2011.07.002","volume":"59","author":"I Gyerty\u00e1n","year":"2011","unstructured":"Gyerty\u00e1n I, Kiss B, S\u00e1ghy K, Laszy J, Szab\u00f3 G, Szabados T, G\u00e9mesi LI, P\u00e1sztor G, Z\u00e1jer-Bal\u00e1zs M, Kap\u00e1s M, Csongor E\u00c1, Dom\u00e1ny G, Tihanyi K, Szombathelyi Z (2011) Cariprazine (RGH-188), a potent D3\/D2 dopamine receptor partial agonist, binds to dopamine D3 receptors in vivo and shows antipsychotic-like and procognitive effects in rodents. Neurochem Int 59(6):925\u2013935","journal-title":"Neurochem Int"},{"issue":"21","key":"5851_CR26","doi-asserted-by":"publisher","first-page":"3217","DOI":"10.1007\/s00213-017-4703-9","volume":"234","author":"Y Hara","year":"2017","unstructured":"Hara Y, Ago Y, Taruta A, Hasebe S, Kawase H, Tanabe W, Tsukada S, Nakazawa T, Hashimoto H, Matsuda T, Takuma K (2017) Risperidone and aripiprazole alleviate prenatal valproic acid-induced abnormalities in behaviors and dendritic spine density in mice. Psychopharmacology 234(21):3217\u20133228","journal-title":"Psychopharmacology"},{"issue":"1\u20132","key":"5851_CR27","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1007\/BF02245607","volume":"124","author":"P Hertel","year":"1996","unstructured":"Hertel P, Nomikos GG, Iurlo M, Svensson TH (1996) Risperidone: regional effects in vivo on release and metabolism of dopamine and serotonin in the rat brain. Psychopharmacology 124(1\u20132):74\u201386","journal-title":"Psychopharmacology"},{"issue":"2","key":"5851_CR28","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s00213-007-0895-8","volume":"195","author":"JR Homberg","year":"2007","unstructured":"Homberg JR, Schiepers OJ, Schoffelmeer AN, Cuppen E, Vanderschuren LJ (2007) Acute and constitutive increases in central serotonin levels reduce social play behaviour in peri-adolescent rats. Psychopharmacology 195(2):175\u2013182","journal-title":"Psychopharmacology"},{"key":"5851_CR29","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1021\/acschemneuro.6b00415","volume":"8","author":"JR Homberg","year":"2017","unstructured":"Homberg JR, Wohr M, Alenina N (2017) Comeback of the rat in biomedical research. ACS Chem Neurosci 8:900\u2013903","journal-title":"ACS Chem Neurosci"},{"issue":"2","key":"5851_CR30","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1124\/jpet.119.259879","volume":"371","author":"M Huang","year":"2019","unstructured":"Huang M, He W, Kiss B, Farkas B, Adham N, Meltzer HY (2019) The role of dopamine D3 receptor partial agonism in cariprazine-induced neurotransmitter efflux in rat hippocampus and nucleus Accumbens. J Pharmacol Exp Ther 371(2):517\u2013525","journal-title":"J Pharmacol Exp Ther"},{"issue":"11","key":"5851_CR31","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1080\/14740338.2020.1820985","volume":"19","author":"F Iasevoli","year":"2020","unstructured":"Iasevoli F, Barone A, Buonaguro EF, Vellucci L, de Bartolomeis A (2020) Safety and tolerability of antipsychotic agents in neurodevelopmental disorders: a systematic review. Expert Opin Drug Saf 19(11):1419\u20131444","journal-title":"Expert Opin Drug Saf"},{"key":"5851_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neubiorev.2013.12.001","volume":"39","author":"EJ Jones","year":"2014","unstructured":"Jones EJ, Gliga T, Bedford R, Charman T, Johnson MH (2014) Developmental pathways to autism: a review of prospective studies of infants at risk. Neurosci Biobehav Rev 39:1\u201333","journal-title":"Neurosci Biobehav Rev"},{"issue":"4","key":"5851_CR33","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1177\/1362361303007004002","volume":"7","author":"R Jordan","year":"2003","unstructured":"Jordan R (2003) Social play and autistic spectrum disorders: a perspective on theory, implications and educational approaches. Autism 7(4):347\u2013360","journal-title":"Autism"},{"issue":"1\u20132","key":"5851_CR34","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/0006-8993(96)00288-0","volume":"721","author":"T Kagaya","year":"1996","unstructured":"Kagaya T, Yonaga M, Furuya Y, Hashimoto T, Kuroki J, Nishizawa Y (1996) Dopamine D3 agonists disrupt social behavior in rats. Brain Res 721(1\u20132):229\u2013232","journal-title":"Brain Res"},{"issue":"5","key":"5851_CR35","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1007\/s00213-018-4874-z","volume":"235","author":"J Kehr","year":"2018","unstructured":"Kehr J, Yoshitake T, Ichinose F, Yoshitake S, Kiss B, Gyerty\u00e1n I, Adham N (2018) Effects of cariprazine on extracellular levels of glutamate, GABA, dopamine, noradrenaline and serotonin in the medial prefrontal cortex in the rat phencyclidine model of schizophrenia studied by microdialysis and simultaneous recordings of locomotor activity. Psychopharmacology 235(5):1593\u20131607","journal-title":"Psychopharmacology"},{"key":"5851_CR36","doi-asserted-by":"crossref","unstructured":"Kikuchi T, Tottori K, Uwahodo Y, Hirose T, Miwa T, Oshiro Y, Morita S (1995) 7-{4-[4-(2,3-Dichlorophenyl)-1-piperazinyl]butyloxy}\/3,4-dihydro-2(1H)-quinolinone (OPC-14597), a new putative antipsychotic drug with both presynaptic dopamine autoreceptor agonistic activity and postsynaptic D2 receptor antagonistic activity. J Pharmacol Exp Ther 274:329\u2013336","DOI":"10.1016\/S0021-5198(19)50332-8"},{"key":"5851_CR37","doi-asserted-by":"crossref","unstructured":"Kiss B, Horv\u00e1th A, N\u00e9methy Z, Schmidt E, Laszlovszky I, Bugovics G, Fazekas K, Hornok K, Orosz S, Gyerty\u00e1n I, Agai-Csongor E, Dom\u00e1ny G, Tihanyi K, Adham N, Szombathelyi Z (2010) Cariprazine (RGH-188), a dopamine D3 receptor-preferring, D3\/D2 dopamine receptor antagonist-partial agonist antipsychotic candidate: in vitro and neurochemical profile. J Pharmacol Exp Ther 333(1):328\u2013340","DOI":"10.1124\/jpet.109.160432"},{"issue":"suppl 1","key":"5851_CR38","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/S0920-9964(12)70588-1","volume":"136","author":"B Kiss","year":"2012","unstructured":"Kiss B, Horti F, Bobok A (2012) Cariprazine, a D3\/D2 dopamine receptor partial agonist antipsychotic, displays greater D3 receptor occupancy in vivo compared with other antipsychotics. Schizophrenia Research 136(suppl 1):190","journal-title":"Schizophrenia Research"},{"issue":"10","key":"5851_CR39","doi-asserted-by":"publisher","first-page":"4458","DOI":"10.1096\/fj.201700054R","volume":"31","author":"HY Kuo","year":"2017","unstructured":"Kuo HY, Liu FC (2017) Valproic acid induces aberrant development of striatal compartments and corticostriatal pathways in a mouse model of autism spectrum disorder. FASEB J 31(10):4458\u20134471","journal-title":"FASEB J"},{"key":"5851_CR40","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.cppeds.2018.08.015","volume":"48","author":"M Lamy","year":"2018","unstructured":"Lamy M, Erickson CA (2018) Pharmacological management of behavioral disturbances in children and adolescents with autism spectrum disorders. Curr Probl Pediatr Adolesc Health Care 48:250\u2013264","journal-title":"Curr Probl Pediatr Adolesc Health Care"},{"issue":"6","key":"5851_CR41","first-page":"389","volume":"40","author":"S LeClerc","year":"2015","unstructured":"LeClerc S, Easley D (2015) Pharmacological therapies for autism spectrum disorder: a review. P T 40(6):389\u2013397","journal-title":"P T"},{"issue":"10","key":"5851_CR42","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1016\/j.biopsych.2016.05.011","volume":"81","author":"E Lee","year":"2017","unstructured":"Lee E, Lee J, Kim E (2017) Excitation\/inhibition imbalance in animal models of autism spectrum disorders. Biol Psychiatry 81(10):838\u2013847","journal-title":"Biol Psychiatry"},{"key":"5851_CR43","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.euroneuro.2008.07.012","volume":"19","author":"F Loiseau","year":"2009","unstructured":"Loiseau F, Millan MJ (2009) Blockade of dopamine D3 receptors in frontal cortex, but not in sub-cortical structures, enhances social recognition in rats: similar actions of D1 receptor agonists, but not of D2 antagonists. Eur Neuropsychopharmacol 19:23\u201333","journal-title":"Eur Neuropsychopharmacol"},{"issue":"6","key":"5851_CR44","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.jaac.2017.03.013","volume":"56","author":"R Loomes","year":"2017","unstructured":"Loomes R, Hull L, Mandy WPL (2017) What is the male-to-female ratio in autism spectrum disorder? A systematic review and meta-analysis. J Am Acad Child Adolesc Psychiatry 56(6):466\u2013474","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"1","key":"5851_CR45","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/s41572-019-0138-4","volume":"6","author":"C Lord","year":"2020","unstructured":"Lord C, Brugha TS, Charman T, Cusack J, Dumas G, Frazier T, Jones EJH, Jones RM, Pickles A, State MW, Taylor JL, Veenstra-VanderWeele J (2020) Autism spectrum disorder. Nat Rev Dis Primers 6(1):5","journal-title":"Nat Rev Dis Primers"},{"issue":"4","key":"5851_CR46","doi-asserted-by":"publisher","first-page":"285","DOI":"10.5607\/en.2015.24.4.285","volume":"24","author":"DF Mabunga","year":"2015","unstructured":"Mabunga DF, Gonzales EL, Kim JW, Kim KC, Shin CY (2015) Exploring the validity of valproic acid animal model of autism. Exp Neurobiol 24(4):285\u2013300","journal-title":"Exp Neurobiol"},{"key":"5851_CR47","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1038\/npp.2016.22","volume":"41","author":"A Manduca","year":"2016","unstructured":"Manduca A, Servadio M, Damsteegt R, Campolongo P, Vanderschuren LJ, Trezza V (2016) Dopaminergic neurotransmission in the nucleus accumbens modulates social play behavior in rats. Neuropsychopharmacol 41:2215\u20132223","journal-title":"Neuropsychopharmacol"},{"key":"5851_CR48","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1038\/npp.2010.50","volume":"35","author":"PN McCormick","year":"2010","unstructured":"McCormick PN, Kapur S, Graff-Guerrero A, Raymond R, Nobrega JN (2010) The antipsychotics olanzapine, risperidone, clozapine and haloperidol are D2-selective ex vivo but not in vitro. Neuropsychopharmacology 35:1826\u20131835","journal-title":"Neuropsychopharmacology"},{"issue":"5","key":"5851_CR49","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1056\/NEJMoa013171","volume":"347","author":"JT McCracken","year":"2002","unstructured":"McCracken JT, McGough J, Shah B, Cronin P, Hong D, Aman MG, Arnold LE, Lindsay R, Nash P, Hollway J, McDougle CJ, Posey D, Swiezy N, Kohn A, Scahill L, Martin A, Koenig K, Volkmar F, Carroll D, Lancor A, Tierney E, Ghuman J, Gonzalez NM, Grados M, Vitiello B, Ritz L, Davies M, Robinson J, McMahon D, Research Units on Pediatric Psychopharmacology Autism Network (2002) Risperidone in children with autism and serious behavioral problems. N Engl J Med 347(5):314\u2013321","journal-title":"N Engl J Med"},{"issue":"1","key":"5851_CR50","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/0893-133X(95)00150-C","volume":"15","author":"JH Meador-Woodruff","year":"1996","unstructured":"Meador-Woodruff JH, Damask SP, Wang J, Haroutunian V, Davis KL, Watson SJ (1996) Dopamine receptor mRNA expression in human striatum and neocortex. Neuropsychopharmacology 15(1):17\u201329","journal-title":"Neuropsychopharmacology"},{"issue":"7","key":"5851_CR51","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1111\/bph.14923","volume":"177","author":"MA Meier","year":"2019","unstructured":"Meier MA, Lemercier CE, Kulisch C, Kiss B, Lendvai B, Adham N, Gerevich Z (2019) The novel antipsychotic cariprazine stabilizes gamma oscillations in rat hippocampal slices. Br J Pharmacol 177(7):1622\u20131634","journal-title":"Br J Pharmacol"},{"issue":"4","key":"5851_CR52","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1111\/j.1471-4159.2006.04262.x","volume":"100","author":"MJ Millan","year":"2007","unstructured":"Millan MJ, Di Cara B, Dekeyne A, Panayi F, De Groote L, Sicard D, Cistarelli L, Billiras R, Gobert A (2007) Selective blockade of dopamine D(3) versus D(2) receptors enhances frontocortical cholinergic transmission and social memory in rats: a parallel neurochemical and behavioural analysis. J Neurochem 100(4):1047\u20131061","journal-title":"J Neurochem"},{"key":"5851_CR53","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.schres.2011.05.005","volume":"131","author":"R Mizrahi","year":"2011","unstructured":"Mizrahi R, Agid O, Borlido C, Suridjan I, Rusjan P, Houle S, Remington G, Wilson AA, Kapur S (2011) Effects of antipsychotics on D3 receptors: a clinical PET study in first episode antipsychotic naive patients with schizophrenia using [11C]-(+)-PHNO. Schizophrenia Res 131:63\u201368","journal-title":"Schizophrenia Res"},{"key":"5851_CR54","doi-asserted-by":"crossref","unstructured":"Nakajima S, Gerretsen P, Takeuchi H, Caravaggio F, Chow T, Le Foll B, Mulsant B, Pollock B, Graff-Guerrero A (2013) The potential role of dopamine D3 receptor neurotransmission in cognition. Eur Neuropsychopharmacol 23(8):799\u2013813","DOI":"10.1016\/j.euroneuro.2013.05.006"},{"issue":"1","key":"5851_CR55","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1186\/s12888-017-1459-z","volume":"17","author":"HA Nasrallah","year":"2017","unstructured":"Nasrallah HA, Earley W, Cutler AJ, Wang Y, Lu K, Laszlovszky I, N\u00e9meth G, Durgam S (2017) The safety and tolerability of cariprazine in long-term treatment of schizophrenia: a post hoc pooled analysis. BMC Psychiatry 17(1):305","journal-title":"BMC Psychiatry"},{"issue":"1","key":"5851_CR56","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.euroneuro.2015.11.016","volume":"26","author":"JC Neill","year":"2016","unstructured":"Neill JC, Grayson B, Kiss B, Gyerty\u00e1n I, Ferguson P, Adham N (2016) Effects of cariprazine, a novel antipsychotic, on cognitive deficit and negative symptoms in a rodent model of schizophrenia symptomatology. Eur Neuropsychopharmacol 26(1):3\u201314","journal-title":"Eur Neuropsychopharmacol"},{"issue":"10074","key":"5851_CR57","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1016\/S0140-6736(17)30060-0","volume":"389","author":"G N\u00e9meth","year":"2017","unstructured":"N\u00e9meth G, Laszlovszky I, Czobor P, Szalai E, Szatm\u00e1ri B, Hars\u00e1nyi J, Barab\u00e1ssy \u00c1, Debelle M, Durgam S, Bitter I, Marder S, Fleischhacker WW (2017) Cariprazine versus risperidone monotherapy for treatment of predominant negative symptoms in patients with schizophrenia: a randomised, double-blind, controlled trial. Lancet 389(10074):1103\u20131113","journal-title":"Lancet"},{"issue":"Pt A","key":"5851_CR58","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.expneurol.2017.04.017","volume":"299","author":"C Nicolini","year":"2018","unstructured":"Nicolini C, Fahnestock M (2018) The valproic acid-induced rodent model of autism. Exp Neurol 299(Pt A):217\u2013227","journal-title":"Exp Neurol"},{"issue":"6","key":"5851_CR59","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1542\/peds.2008-3782","volume":"124","author":"R Owen","year":"2009","unstructured":"Owen R, Sikich L, Marcus RN, Corey-Lisle P, Manos G, McQuade RD, Carson WH, Findling RL (2009) Aripiprazole in the treatment of irritability in children and adolescents with autistic disorder. Pediatrics 124(6):1533\u20131540","journal-title":"Pediatrics"},{"issue":"50","key":"5851_CR60","doi-asserted-by":"publisher","first-page":"16352","DOI":"10.1523\/JNEUROSCI.1442-15.2015","volume":"35","author":"I Peiker","year":"2015","unstructured":"Peiker I, David N, Schneider TR, Nolte G, Sch\u00f6ttle D, Engel AK (2015) Perceptual integration deficits in autism spectrum disorders are associated with reduced interhemispheric gamma-band coherence. J Neurosci 35(50):16352\u201316361","journal-title":"J Neurosci"},{"key":"5851_CR61","doi-asserted-by":"publisher","first-page":"295","DOI":"10.3389\/fnbeh.2019.00295","volume":"13","author":"P Pels\u0151czi","year":"2020","unstructured":"Pels\u0151czi P, Kelemen K, Cs\u00f6lle C, Nagy G, Lendvai B, Rom\u00e1n V, L\u00e9vay G (2020) Disrupted social hierarchy in prenatally valproate-exposed autistic-like rats. Front Behav Neurosci 13:295","journal-title":"Front Behav Neurosci"},{"issue":"1","key":"5851_CR62","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.cell.2011.08.040","volume":"147","author":"O Penagarikano","year":"2011","unstructured":"Penagarikano O, Abrahams BS, Herman EI, Winden KD, Gdalyahu A, Dong H, Sonnenblick LI, Gruver R, Almajano J, Bragin A, Golshani P, Trachtenberg JT, Peles E, Geschwind DH (2011) Absence of CNTNAP2 leads to epilepsy, neuronal migration abnormalities, and core autism-related deficits. Cell 147(1):235\u2013246","journal-title":"Cell"},{"issue":"4","key":"5851_CR63","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.chc.2008.06.010","volume":"17","author":"DJ Posey","year":"2008","unstructured":"Posey DJ, Erickson CA, McDougle CJ (2008) Developing drugs for core social and communication impairment in autism. Child Adolesc Psychiatr Clin N Am 17(4):787\u2013801","journal-title":"Child Adolesc Psychiatr Clin N Am"},{"issue":"1","key":"5851_CR64","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1007\/s002130050981","volume":"144","author":"M Rodr\u00edguez-Arias","year":"1999","unstructured":"Rodr\u00edguez-Arias M, Felip CM, Broseta I, Mi\u00f1arro J (1999) The dopamine D3 antagonist U-99194A maleate increases social behaviors of isolation-induced aggressive male mice. Psychopharmacology 144(1):90\u201394","journal-title":"Psychopharmacology"},{"issue":"3","key":"5851_CR65","doi-asserted-by":"publisher","first-page":"353","DOI":"10.2217\/bmm.14.15","volume":"8","author":"DC Rojas","year":"2014","unstructured":"Rojas DC, Wilson LB (2014) \u03b3-band abnormalities as markers of autism spectrum disorders. Biomark Med 8(3):353\u2013368","journal-title":"Biomark Med"},{"issue":"401","key":"5851_CR66","doi-asserted-by":"publisher","first-page":"eaah6733","DOI":"10.1126\/scitranslmed.aah6733","volume":"9","author":"A Selimbeyoglu","year":"2017","unstructured":"Selimbeyoglu A, Kim CK, Inoue M, Lee SY, Hong ASO, Kauvar I, Ramakrishnan C, Fenno LE, Davidson TJ, Wright M, Deisseroth K (2017) Modulation of prefrontal cortex excitation\/inhibition balance rescues social behavior in CNTNAP2-deficient mice. Sci Transl Med 9(401):eaah6733","journal-title":"Sci Transl Med"},{"issue":"1","key":"5851_CR67","doi-asserted-by":"publisher","first-page":"9225","DOI":"10.1038\/s41598-019-45667-1","volume":"9","author":"T Spis\u00e1k","year":"2019","unstructured":"Spis\u00e1k T, Rom\u00e1n V, Papp E, Kedves R, S\u00e1ghy K, Cs\u00f6lle CK, Varga A, Gaj\u00e1ri D, Nyitrai G, Spis\u00e1k Z, Kincses ZT, L\u00e9vay G, Lendvai B, Czurk\u00f3 A (2019) Purkinje cell number-correlated cerebrocerebellar circuit anomaly in the valproate model of autism. Sci Rep 9(1):9225","journal-title":"Sci Rep"},{"issue":"9","key":"5851_CR68","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1038\/s41380-019-0426-0","volume":"24","author":"VS Sohal","year":"2019","unstructured":"Sohal VS, Rubenstein JLR (2019) Excitation-inhibition balance as a framework for investigating mechanisms in neuropsychiatric disorders. Mol Psychiatry 24(9):1248\u20131257","journal-title":"Mol Psychiatry"},{"issue":"2","key":"5851_CR69","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s00210-012-0797-0","volume":"386","author":"P Sokoloff","year":"2013","unstructured":"Sokoloff P, Leriche L, Diaz J, Louvel J, Pumain R (2013) Direct and indirect interactions of the dopamine D3 receptor with glutamate pathways: implications for the treatment of schizophrenia Naunyn Schmiedebergs. Arch Pharmacol 386(2):107\u2013124","journal-title":"Arch Pharmacol"},{"key":"5851_CR70","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/ejn.13390","volume":"45","author":"P Sokoloff","year":"2017","unstructured":"Sokoloff P, Le Foll B (2017) The dopamine D3 receptor, a quarter century later. Eur J Neurosci 45:2\u201319","journal-title":"Eur J Neurosci"},{"key":"5851_CR71","doi-asserted-by":"publisher","first-page":"61","DOI":"10.3389\/fpsyt.2020.00061","volume":"11","author":"B Szatm\u00e1ri","year":"2020","unstructured":"Szatm\u00e1ri B, Barab\u00e1ssy \u00c1, Hars\u00e1nyi J, Laszlovszky I, Sebe B, G\u00e1l M, Shiragami K, N\u00e9meth G (2020) Cariprazine safety in adolescents and the elderly: analyses of clinical study data. Front Psychiatry 11:61","journal-title":"Front Psychiatry"},{"key":"5851_CR72","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.ejphar.2011.07.020","volume":"668","author":"Y Tadori","year":"2011","unstructured":"Tadori Y, Forbes RA, McQuade RD, Kikuchi T (2011a) In vitro pharmacology of aripiprazole, its metabolite and experimental dopamine partial agonists at human dopamine D2 and D3 receptors. Eur J Pharmacol 668:355\u2013365","journal-title":"Eur J Pharmacol"},{"key":"5851_CR73","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.ejphar.2011.05.050","volume":"666","author":"Y Tadori","year":"2011","unstructured":"Tadori Y, Forbes RA, McQaude RD, Kikuchi T (2011b) Functional potencies of dopamine agonists and antagonists at human dopamine D2 and D3 receptors. Eur J Pharmacol 666:43\u201352","journal-title":"Eur J Pharmacol"},{"key":"5851_CR74","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.neuropharm.2015.12.025","volume":"105","author":"BL Teng","year":"2016","unstructured":"Teng BL, Nikolova VD, Riddick NV, Agster KL, Crowley JJ, Baker LK, Koller BH, Pedersen CA, Jarstfer MB, Moy SS (2016) Reversal of social deficits by subchronic oxytocin in two autism mouse models. Neuropharmacology 105:61\u201371","journal-title":"Neuropharmacology"},{"issue":"10","key":"5851_CR75","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.tips.2010.06.008","volume":"31","author":"V Trezza","year":"2010","unstructured":"Trezza V, Baarendse PJ, Vanderschuren LJ (2010) The pleasures of play: pharmacological insights into social reward mechanisms. Trends Pharmacol Sci 31(10):463\u2013469","journal-title":"Trends Pharmacol Sci"},{"issue":"9","key":"5851_CR76","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1097\/00001756-199506090-00027","volume":"6","author":"K Uvn\u00e4s-Moberg","year":"1995","unstructured":"Uvn\u00e4s-Moberg K, Alster P, Hillegaart V, Ahlenius S (1995) Suggestive evidence for a DA D3 receptor-mediated increase in the release of oxytocin in the male rat. NeuroReport 6(9):1338\u20131340","journal-title":"NeuroReport"},{"key":"5851_CR77","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/978-3-662-45758-0_268","volume":"16","author":"LJ Vanderschuren","year":"2014","unstructured":"Vanderschuren LJ, Trezza V (2014) What the laboratory rat has taught us about social play behavior: role in behavioral development and neural mechanisms. Curr Top Behav Neurosci 16:189\u2013212","journal-title":"Curr Top Behav Neurosci"},{"issue":"2","key":"5851_CR78","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.euroneuro.2015.12.020","volume":"26","author":"DJG Watson","year":"2016","unstructured":"Watson DJG, King MV, Gyerty\u00e1n I, Kiss B, Adham N, Fone KCF (2016) The dopamine D3-preferring D2\/D3 dopamine receptor partial agonist, cariprazine, reverses behavioural changes in a rat neurodevelopmental model for schizophrenia. Eur Neuropsychopharmacol 26(2):208\u2013224","journal-title":"Eur Neuropsychopharmacol"},{"key":"5851_CR79","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1017\/S146114570500516X","volume":"8","author":"ND Woodward","year":"2005","unstructured":"Woodward ND, Purdon SE, Meltzer HY, Zald DH (2005) A meta-analysis of neuropsychological change to clozapine, olanzapine, quetiapine, and risperidone in schizophrenia. Int J Neuropsychopharm 8:457\u2013472","journal-title":"Int J Neuropsychopharm"},{"key":"5851_CR80","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1016\/j.celrep.2016.06.098","volume":"16","author":"S Yang","year":"2016","unstructured":"Yang S, Ben-Shalom R, Ahn M, Liptak AT, van Rijn RM, Whistler JL, Bender KJ (2016) \u03b2-Arrestin-dependent dopaminergic regulation of calcium channel activity in the axon initial segment. Cell Rep 16:1518\u20131526","journal-title":"Cell Rep"},{"issue":"3","key":"5851_CR81","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1097\/YIC.0000000000000307","volume":"35","author":"LN Yatham","year":"2020","unstructured":"Yatham LN, Vieta E, Earley W (2020) Evaluation of cariprazine in the treatment of bipolar I and II depression: a randomized, double-blind, placebo-controlled, phase 2 trial. Int Clin Psychopharmacol 35(3):147\u2013156","journal-title":"Int Clin Psychopharmacol"},{"issue":"7363","key":"5851_CR82","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/nature10360","volume":"477","author":"O Yizhar","year":"2011","unstructured":"Yizhar O, Fenno LE, Prigge M, Schneider F, Davidson TJ, O\u2019Shea DJ, Sohal VS, Goshen I, Finkelstein J, Paz JT, Stehfest K, Fudim R, Ramakrishnan C, Huguenard JR, Hegemann P, Deisseroth K (2011) Neocortical excitation\/inhibition balance in information processing and social dysfunction. Nature 477(7363):171\u2013178","journal-title":"Nature"},{"issue":"1","key":"5851_CR83","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41398-020-0692-2","volume":"10","author":"L Zhang","year":"2020","unstructured":"Zhang L, Huang CC, Dai Y, Luo Q, Ji Y, Wang K, Deng S, Yu J, Xu M, Du X, Tang Y, Shen C, Feng J, Sahakian BJ, Lin CP, Li F (2020) Symptom improvement in children with autism spectrum disorder following bumetanide administration is associated with decreased GABA\/glutamate ratios. Transl Psychiatry 10(1):9","journal-title":"Transl Psychiatry"},{"issue":"1","key":"5851_CR84","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s00213-012-2896-5","volume":"226","author":"R Zimnisky","year":"2013","unstructured":"Zimnisky R, Chang G, Gyerty\u00e1n I, Kiss B, Adham N, Schmauss C (2013) Cariprazine, a Dopamine D(3)-receptor-preferring partial agonist, blocks phencyclidine-induced impairments of working memory, attention set-shifting, and recognition memory in the mouse. Psychopharmacology 226(1):91\u2013100","journal-title":"Psychopharmacology"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-021-05851-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00213-021-05851-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-021-05851-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,18]],"date-time":"2021-08-18T16:05:05Z","timestamp":1629302705000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00213-021-05851-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,15]]},"references-count":84,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["5851"],"URL":"https:\/\/doi.org\/10.1007\/s00213-021-05851-6","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,15]]},"assertion":[{"value":"6 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"VR, BF, BL, and BK are employees of Gedeon Richter Plc. NA is an employee of AbbVie. AF and LH are employees of Berand Neuropharmacology Limited, which was contracted to perform the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}